PharMerica Inactive 10-Q2010 Q1 Quarterly report

Filed: 7 May 10, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Bad

New words: Affordability, Affordable, automated, awaiting, biological, Biosimilar, capped, carryforward, catastrophic, clean, closure, coinsurance, compliant, creditor, daily, deadline, detect, deter, Discrepancy, Donut, epidemic, escrow, exposure, faith, Flag, forecast, forfeiture, FTC, FUL, gap, good, gradual, gradually, hereinafter, Holdback, Hole, IMS, Indemnity, ingredient, innovator, instance, Interbank, intrinsic, IPS, judicial, jurisdiction, larger, LLC, London, MAPD, membership, modification, pandemic, pathway, pressure, progression, promissory, publishedOIG, Red, refused, respond, Safari, Secretary, seller, shorter, sufficient, SupplementalCompliance, surviving, synergistic, theft, therewith, transition, unexercised, uniform, Virginia, weekly, West, withdrawn

Removed: accountability, accredited, ad, aforementioned, aggregation, altered, amortizable, analyzing, April, aspect, awarded, back, BAE, blended, broadening, cancer, caption, CIA, comparing, confidential, deemed, delayed, derivative, designate, disciplinary, disregarded, district, educational, eliminate, encouraging, ethical, Evidence, exceeded, expiring, extensive, FASB, finite, formula, found, fundamental, hedge, hedged, highlight, hoc, House, imposition, incorporated, increasing, ineffective, ineligible, injunction, introducing, joint, lead, legislatively, lived, low, November, Obama, OIG, operation, outreach, oversight, parallel, penalty, permanent, planned, positively, posting, predict, prescribe, productive, prohibiting, promote, promotion, promulgated, protected, public, reached, rebid, reclassified, recommendation, refinance, remedied, repeatedly, replaced, research, roughly, screening, scrutiny, select, Senate, shared, simultaneously, stipulated, subsidy, turnover, twelve, undertaken, warehousing, write

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

PharMerica similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of PharMerica Corporation (the “Corporation”) on Form 10-Q for the quarter ended March 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Gregory S. Weishar, Chief Executive Officer and Director of the Corporation, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition, and results of operations of the Corporation.

/s/ GREGORY S. WEISHAR

Gregory S. Weishar

Chief Executive Officer and Director

May 7, 2010